Updated:
Arimed Capital
Arimed Capital is a global investment entity with offices across the US, Europe, and Asia, focusing on healthcare, life sciences, and real estate.
Arimed Capital
Arimed Capital operates as an investment entity with a global office network that includes New York, Ingelheim am Rhein (Germany), Baltimore, Boston, Cambridge (Massachusetts), and Shanghai — indicating a strategy covering North America, Europe, and Asia. The firm's presence in Ingelheim am Rhein, a hub for pharmaceutical and life sciences activity, alongside multiple US biotech centers, points to a sector focus on healthcare and life sciences. The firm's historical activity suggests engagement across healthcare services, life sciences, and real estate, though specific deployment figures and asset-class allocations remain undisclosed. Geographic coverage across three continents implies the firm sources deals directly and likely participates in co-investments or club deals with other family offices and institutional partners. No named portfolio companies or co-investors have been publicly identified. Team size, total deployment, and founding year are not publicly available. Additional offices beyond the six confirmed locations have not been disclosed. The firm maintains no known philanthropic vehicles, operating businesses, or advisory boards in the public record. No recent operational events from the last 24 months have been reported. The firm's structural differentiator is its unusual geographic bridge — offices in a German pharma center (Ingelheim am Rhein), US biotech corridors (Baltimore, Boston, Cambridge), a financial capital (New York), and a Chinese commercial hub (Shanghai). This multi-continent network, rare for an entity with limited public footprint, suggests a mandate tied to cross-border healthcare and life sciences investments, though the absence of named principals or a founding history leaves the firm's governance and wealth origin opaque.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Additional offices
Ingelheim am Rhein, Germany · Baltimore, MD, United States · Boston, MA, United States · Cambridge, MA, United States · Shanghai, China
Sector focus
Frequently asked questions
Who runs investment decisions at Arimed Capital?
Arimed Capital has not publicly disclosed the names or titles of its investment principals (public record). Without named leadership, the firm's governance structure remains unknown, though the geographic diversity of its offices suggests distributed decision-making across its North American, European, and Asian hubs.
How does Arimed Capital source proprietary deal flow?
Arimed Capital's office locations in Ingelheim am Rhein, Baltimore, Boston, Cambridge, New York, and Shanghai imply a sourcing network rooted in life sciences clusters and financial centers (public record). The firm likely leverages local relationships in these regions to access private deals, though no sourcing model has been explicitly described.
Is Arimed Capital structured as a single family office or does it operate more like a venture firm?
Arimed Capital's structure is not publicly classified as a single or multi-family office (public record). The firm's multiple offices and cross-sector focus (healthcare, life sciences, real estate) suggest it may operate with a family office investment mandate, but the absence of owner or beneficiary information leaves its exact structure unclear.
Does Arimed Capital participate in fund commitments or only direct deals?
Arimed Capital has not disclosed its investment vehicle preferences (public record). Given its office footprint spanning multiple countries, the firm could engage in both direct investments and fund-of-funds or co-investment structures, but no definitive evidence is available.
What investment stages does Arimed Capital typically target?
Arimed Capital's stage focus is not specified in public sources (public record). The firm's implied sector interest in healthcare and life sciences could align with early-stage venture, growth equity, or real asset investments, but no stage preferences have been confirmed.
Which sectors does Arimed Capital focus on?
Arimed Capital's known sector interests include healthcare services, life sciences, and real estate, inferred from its office locations in life sciences hubs and financial centers (public record). No explicit sector exclusions have been published.
Where does the underlying wealth come from?
The source of capital managed by Arimed Capital has not been publicly disclosed (public record). Without named principals or a founding family, the wealth origin remains unattributed, though the Ingelheim am Rhein office may hint at connections to German pharmaceutical wealth or industry.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: